{"schema_version":"secwatch.filing_event.v1","accession":"0001559053-24-000023","form_type":"8-K","ticker":"PRTA","cik":"0001559053","company_name":"PROTHENA CORP PUBLIC LTD CO","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.505229+00:00","generated_at":"2026-05-31T10:54:06.694833+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Prothena Q2 net income $66.9M; BMS licenses PRX019 for $80M; year-end cash guidance raised to $468M","bullets":["Q2 net income $66.9M (diluted EPS $1.22) vs net loss $54.6M in Q2 2023; revenue $132M vs $4M.","BMS obtained exclusive global license for PRX019 for $80M upfront; potential milestones up to $617.5M.","Year-end cash guidance raised to ~$468M from $405M; net cash used guidance reduced to $148-160M.","Topline results expected: prasinezumab Phase 2b (2H 2024), birtamimab Phase 3 (4Q24-2Q25), coramitug Phase 2 (1H25).","Cash and restricted cash $565M as of June 30, 2024; no debt; ~53.8M shares outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001559053-24-000023","json":"https://secwatch.observer/filing/0001559053-24-000023.json","markdown":"https://secwatch.observer/filing/0001559053-24-000023.md","text":"https://secwatch.observer/filing/0001559053-24-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1559053/000155905324000023/0001559053-24-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1559053/000155905324000023/prta-20240808.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:54:06.694833+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}